drugset / Trial / NCT02927223

Atropine in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

NCT02927223

Completed 6 enrolled Vanderbilt University
NaSingle-groupOpen-labelOther

Summary

To test the hypothesis that increasing the sinus node rate with atropine treatment prior to exercise will reduce exercise-triggered ventricular ectopy compared to baseline in patients with CPVT.

Timeline

Start
2016-10
Primary completion
2019-02
Completion
2019-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Atropine Other / unclassified 0.04 mg/kg Intravenous